Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 16/20 | 0.64 |
| ▸ | ERBB2 | P04626 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.51 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.46 |
| ▸ | BRAF | P15056 | 2/20 | 0.45 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8312893 | 0.90 | EGFR (0.64) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8317451 | 0.89 | EGFR (0.69) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8317682 | 0.88 | EGFR (0.70) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL6997407 | 0.88 | EGFR (0.61) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8314655 | 0.86 | EGFR (0.59) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL6993117 | 0.86 | EGFR (0.59) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8315059 | 0.85 | EGFR (0.60) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL7587577 | 0.85 | EGFR (0.57) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL7584698 | 0.85 | EGFR (0.58) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL6991323 | 0.84 | EGFR (0.61) | EGFRERBB2HPGDHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5977102-A | INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; | DR. KARL THOMAE GMBH (DE) | 1999-11-02 | — | — | US | disclosed |